You are here: Industry Insights > GRAM

News List

GRAM Expands Footprint with New Finishing Center contractpharma
August 09, 2021
New 110,000 sq.-ft. finishing center is the injectable CDMO's fourth GMP manufacturing facility.
GRAM Attains EU GMP Certification for Commercial Aseptic Fill/Finish contractpharma
March 31, 2021
Grand River Aseptic Manufacturing (GRAM), an injectable CDMO, was recently audited by the Dutch Health and Youth Care Inspectorate (IGJ) and issued EU Good Manufacturing Practices (EU GMP) certificate.
GRAM, J&J Enter COVID-19 Vax Manufacturing Pact contractpharma
September 27, 2020
GRAM to provide advanced aseptic fill and finish services for supply of J&J’s SARS-CoV-2 vaccine candidate from its facility in Grand Rapids, MI.
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19 contractpharma
August 11, 2020
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed.
GRAM Opens Large-Scale Injectable Fill/Finish Facility contractpharma
July 06, 2020
Grand River Aseptic Manufacturing (GRAM), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.
GRAM Grows Team to Serve New Facility contractpharma
March 09, 2020
Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization (CDMO), has added Mary Lou Glotzbach to the GRAM team.
Grand River Ranked on the Inc. 5000 List for Third Consecutive Year contractpharma
August 26, 2019
The parenteral CDMO is set to open its third facility in 2020.
GRAM Announces Successful FDA Inspection contractpharma
November 12, 2018
GRAM Announces Successful FDA Inspection